NNE - NASDAQ
Nano Nuclear Energy Inc
$26.37
-14%NANO Nuclear Energy Inc. operates as a microreactor technology company. The company is developing ZEUS, a solid-core battery reactor, and ODIN, a low-pressure coolant reactor. It is also developing a high-assay low-enriched uranium fabrication facility to supply fuel to the nuclear reactor industry and fuel transportation and nuclear consultation businesses. The company was founded in 2021 and is based in New York, New York.
At a Glance
Live Snapshotnne
Property, Plant, and Equipment (Net)
Last Annual Value
12.34M
3-Year CAGR
%
5-Year CAGR
%
10-Year CAGR
%
Nano Nuclear Energy Inc Competitors Analysis of Property, Plant, and Equipment (Net)
| Company | Property, Plant, and Equipment (Net) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
Nano Nuclear Energy Inc NASDAQ:NNE | 12.34M | N/A | N/A | N/A | |
 Hillenbrand, Inc. NYSE:HI | 342.60M | -7.4% | -4.6% | 8.4% | |
 DXP Enterprises, Inc. NASDAQ:DXPE | 189.53M | 19.8% | 11.7% | 12.0% | |
 Helios Technologies, Inc. NYSE:HLIO | 206.60M | -3.2% | 3.5% | 9.9% | |
 Enerpac Tool Group Corp. NYSE:EPAC | 53.27M | 11.0% | 1.9% | -7.3% | |
 Power Solutions International, Inc. NASDAQ:PSIX | 75.92M | 21.7% | 19.7% | 14.2% | |
 Xometry, Inc. NASDAQ:XMTR | 71.76M | 14.4% | 13.7% | N/A | |
 PureCycle Technologies, Inc. NASDAQ:PCT | 711.98M | 2.1% | 25.9% | N/A | |
 Enovis Corporation NYSE:ENOV | 579.32M | 20.1% | 13.2% | -0.4% | |
 CECO Environmental Corp. NASDAQ:CECO | 76.06M | 21.4% | 23.2% | 10.8% |
Nano Nuclear Energy Inc Fair Value Envelope
Related Guides
Continue your NNE research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.